236 related articles for article (PubMed ID: 17645376)
21. Hyperandrogenemia association with acne and hirsutism severity in Croatian women with polycystic ovary syndrome.
Pavičić Baldani D; Škrgatić L; Bukvić Mokos Z; Trgovčić I
Acta Dermatovenerol Croat; 2013; 21(2):105-12. PubMed ID: 24001418
[TBL] [Abstract][Full Text] [Related]
22. Evidence-based approach to cutaneous hyperandrogenism in women.
Schmidt TH; Shinkai K
J Am Acad Dermatol; 2015 Oct; 73(4):672-90. PubMed ID: 26138647
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS).
Artar G; Tas B; Turan G; Uckan HH
Gynecol Endocrinol; 2022 Dec; 38(12):1104-1108. PubMed ID: 36579834
[TBL] [Abstract][Full Text] [Related]
24. Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism.
Unluhizarci K; Kaltsas G; Kelestimur F
Eur J Clin Invest; 2012 Jan; 42(1):86-94. PubMed ID: 21623779
[TBL] [Abstract][Full Text] [Related]
25. Pharmacologic treatment of polycystic ovary syndrome.
Ehrmann DA; Rychlik D
Semin Reprod Med; 2003 Aug; 21(3):277-83. PubMed ID: 14593550
[TBL] [Abstract][Full Text] [Related]
26. Early diagnosis, presenting complaints, and management of hyperandrogenism in adolescents.
Schroeder B
Curr Womens Health Rep; 2001 Oct; 1(2):124-30. PubMed ID: 12112959
[TBL] [Abstract][Full Text] [Related]
27. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
Rosenfield RL; Lucky AW
Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis of hyperandrogenism: clinical criteria.
Yildiz BO
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):167-76. PubMed ID: 16772149
[TBL] [Abstract][Full Text] [Related]
30. [Hyperandrogenism, adrenal dysfunction, and hirsutism].
Makrantonaki E; Zouboulis CC
Hautarzt; 2020 Oct; 71(10):752-761. PubMed ID: 32857168
[TBL] [Abstract][Full Text] [Related]
31. Polycystic ovary syndrome: a common reproductive and metabolic disorder necessitating early recognition and treatment.
Futterweit W
Prim Care; 2007 Dec; 34(4):761-89, vi. PubMed ID: 18061817
[TBL] [Abstract][Full Text] [Related]
32. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study.
Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E
J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563
[TBL] [Abstract][Full Text] [Related]
33. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
34. Is acne a sign of androgen excess disorder or not?
Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
[TBL] [Abstract][Full Text] [Related]
35. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
36. Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review.
Mason H; Colao A; Blume-Peytavi U; Rice S; Qureshi A; Pellatt L; Orio F; Atkin SL
Clin Endocrinol (Oxf); 2008 Dec; 69(6):831-44. PubMed ID: 18616705
[No Abstract] [Full Text] [Related]
37. Polycystic ovary syndrome: an endocrine and metabolic disease.
Scarpitta AM; Sinagra D
Gynecol Endocrinol; 2000 Oct; 14(5):392-5. PubMed ID: 11109980
[TBL] [Abstract][Full Text] [Related]
38. Endocrine-metabolic effects of the treatment with pioglitazone in obese patients with polycystic ovary syndrome.
Garmes HM; Tambascia MA; Zantut-Wittmann DE
Gynecol Endocrinol; 2005 Dec; 21(6):317-23. PubMed ID: 16390779
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous manifestation of polycystic ovary syndrome.
Abusailik MA; Muhanna AM; Almuhisen AA; Alhasanat AM; Alshamaseen AM; Bani Mustafa SM; Nawaiseh MB
Dermatol Reports; 2021 Aug; 13(2):8799. PubMed ID: 34659671
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic approach to androgen disorders in women: acne, hirsutism, and alopecia.
Redmond GP; Bergfeld WF
Cleve Clin J Med; 1990; 57(5):423-7. PubMed ID: 2142637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
